Literature DB >> 29480188

Human Gut Microbiota in Health and Alzheimer's Disease.

Leszek Szablewski1.   

Abstract

Gut microbiota plays a crucial role in human health and disease. The alterations in the composition of gut microbiota may cause the onset of certain human pathologies. One of these is Alzheimer's disease (AD). High-fat diets, administration of antibiotics, lack of probiotics and/or prebiotics in diet increase the risk of AD. On the other hand, modulation of the composition of gut microbiota may decrease the risk of AD and be able to slow down the progression of AD.

Entities:  

Keywords:  Alzheimer’s disease; dysbiosis; gut microbiota; metabolic endotoxemia; physiology

Mesh：

Year:  2018        PMID： 29480188     DOI： 10.3233/JAD-170908

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


  23 in total

Review 1.  Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.

Authors:  Ankita Banerjee; Lilesh Kumar Pradhan; Santosh Chauhan; Pradyumna Kumar Sahoo; Kautilya Kumar Jena; Nishant Ranjan Chauhan; Saroj Kumar Das
Journal:  Arch Microbiol       Date:  2021-03-24       Impact factor: 2.552

Review 2.  Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease.

Authors:  Anna Atlante; Giuseppina Amadoro; Antonella Bobba; Valentina Latina
Journal:  Cells       Date:  2020-10-23       Impact factor: 6.600

Review 3.  Gut Microbiota: From the Forgotten Organ to a Potential Key Player in the Pathology of Alzheimer's Disease.

Authors:  Dong-Oh Seo; David M Holtzman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

Review 4.  Nutrients in the Prevention of Alzheimer's Disease.

Authors:  Anna Laura Cremonini; Irene Caffa; Michele Cea; Alessio Nencioni; Patrizio Odetti; Fiammetta Monacelli
Journal:  Oxid Med Cell Longev       Date:  2019-09-04       Impact factor: 6.543

5.  Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.

Authors:  Ravinder Nagpal; Bryan J Neth; Shaohua Wang; Suzanne Craft; Hariom Yadav
Journal:  EBioMedicine       Date:  2019-08-30       Impact factor: 8.143

Review 6.  Re-thinking the Etiological Framework of Neurodegeneration.

Authors:  Ximena Castillo; Susana Castro-Obregón; Benjamin Gutiérrez-Becker; Gabriel Gutiérrez-Ospina; Nikolaos Karalis; Ahmed A Khalil; José Sócrates Lopez-Noguerola; Liliana Lozano Rodríguez; Eduardo Martínez-Martínez; Claudia Perez-Cruz; Judith Pérez-Velázquez; Ana Luisa Piña; Karla Rubio; Héctor Pedro Salazar García; Tauqeerunnisa Syeda; America Vanoye-Carlo; Arno Villringer; Katarzyna Winek; Marietta Zille
Journal:  Front Neurosci       Date:  2019-07-24       Impact factor: 4.677

7.  Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Harpreet Kaur; Svetlana Golovko; Mikhail Y Golovko; Surjeet Singh; Diane C Darland; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling.

Authors:  Florencia Andrea Ceppa; Luca Izzo; Lorenzo Sardelli; Ilaria Raimondi; Marta Tunesi; Diego Albani; Carmen Giordano
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

Review 9.  Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and Hypothetical Contribution of Environmental Glyphosate Levels.

Authors:  Isadora Argou-Cardozo; Fares Zeidán-Chuliá
Journal:  Med Sci (Basel)       Date:  2018-04-04

Review 10.  Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials.

Authors:  Haoyue Den; Xunhu Dong; Mingliang Chen; Zhongmin Zou
Journal:  Aging (Albany NY)       Date:  2020-02-15       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.